关注
Hirokazu Tanaka
Hirokazu Tanaka
Division of Population Data Science, Institute for Cancer Control, National Cancer Center
在 ncc.go.jp 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies
M Hori, H Tanaka, K Wakai, S Sasazuki, K Katanoda
Japanese journal of clinical oncology 46 (10), 942-951, 2016
1062016
Mortality inequalities by occupational class among men in Japan, South Korea and eight European countries: a national register-based study, 1990–2015
H Tanaka, WJ Nusselder, M Bopp, H Brønnum-Hansen, R Kalediene, ...
J Epidemiol Community Health 73 (8), 750-758, 2019
492019
Widening socioeconomic inequalities in smoking in Japan, 2001–2016
H Tanaka, JP Mackenbach, Y Kobayashi
Journal of Epidemiology 31 (6), 369-377, 2021
392021
Changes in mortality inequalities across occupations in Japan: a national register based study of absolute and relative measures, 1980-2010
H Tanaka, S Toyokawa, N Tamiya, H Takahashi, H Noguchi, Y Kobayashi
BMJ open 7 (9), e015764, 2017
312017
Variation in process quality measures of diabetes care by region and institution in Japan during 2015–2016: an observational study of nationwide claims data
T Sugiyama, K Imai, N Ihana-Sugiyama, H Tanaka, A Yanagisawa-Sugita, ...
diabetes research and clinical practice 155, 107750, 2019
292019
Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan
H Tanaka, J Tomio, T Sugiyama, Y Kobayashi
BMJ Open Diabetes Research and Care 4 (1), e000291, 2016
252016
Informal caregiving and mortality―Who is protected and who is not? A prospective cohort study from Japan
A Miyawaki, H Tanaka, Y Kobayashi, I Kawachi
Social Science & Medicine 223, 24-30, 2019
232019
Geographic access to cancer treatment in Japan: results from a combined dataset of the patient survey and the survey of medical institutions in 2011
H Tanaka, KB Ishikawa, K Katanoda
Journal of Epidemiology 28 (11), 470-475, 2018
182018
Relationship of relative poverty and social relationship on mortality around retirement: a 10-year follow-up of the Komo-Ise cohort
H Tanaka, A Miyawaki, S Toyokawa, Y Kobayashi
Environmental Health and Preventive Medicine 23, 1-10, 2018
172018
Changes in the quality of diabetes care in Japan between 2007 and 2015: A repeated cross-sectional study using claims data
H Tanaka, T Sugiyama, N Ihana-Sugiyama, K Ueki, Y Kobayashi, ...
diabetes research and clinical practice 149, 188-199, 2019
152019
Mortality by occupation and industry among Japanese men in the 2015 fiscal year
H Tanaka, T Tanaka, K Wada
Environmental health and preventive medicine 25, 1-8, 2020
132020
Contribution of diabetes to the incidence and prevalence of comorbid conditions (cancer, periodontal disease, fracture, impaired cognitive function, and depression): a …
H Tanaka, N Ihana-Sugiyama, T Sugiyama, M Ohsugi
Journal of Epidemiology 29 (1), 1-10, 2019
132019
Practical implications of the update to the 2015 Japan Standard Population: mortality archive from 1950 to 2020 in Japan
H Tanaka, S Tanaka, K Togawa, K Katanoda
Journal of Epidemiology 33 (7), 372-380, 2023
92023
職業別喫煙率とその推移:国民生活基礎調査による分析(2001-2016年)
田中宏和, 小林廉毅
日本公衆衛生雑誌 68 (6), 433-443, 2021
9*2021
Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan
T Nakao, R Kaneko, H Tanaka, S Kobayashi, R Omori, Y Yano, K Kamada, ...
International Journal of Clinical Oncology 26, 378-386, 2021
92021
Gastric cancer mortality rates by occupation and industry among male and female workers aged 25–64 years in Japan
Y Yoshinaga, H Tanaka, K Wada, S Ikeda
Industrial health 58 (6), 554-564, 2020
92020
Trends and socioeconomic inequalities in self-rated health in Japan, 1986–2016
H Tanaka, JP Mackenbach, Y Kobayashi
BMC Public Health 21, 1-13, 2021
82021
Diagnosis and medical care for congenital cytomegalovirus infection: An observational study using claims data in Japan, 2010 to 2017
C Lin, J Tomio, H Tanaka, M Sonoda, K Sano, Y Kobayashi
Medicine 99 (10), e19419, 2020
82020
健康保険組合レセプトデータ分析によるがん患者の受療医療施設の分布
田中宏和, 中村文明, 東尚弘, 小林廉毅
日本公衆衛生雑誌 62 (1), 28-38, 2015
8*2015
Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working …
N Ihana‐Sugiyama, T Sugiyama, H Tanaka, K Ueki, Y Kobayashi, ...
Journal of Evaluation in Clinical Practice 26 (1), 299-307, 2020
72020
系统目前无法执行此操作,请稍后再试。
文章 1–20